Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-25 @ 8:07 PM
NCT ID:
NCT01868035
Pre Assignment Details:
All participants were treated with 6 to 8 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy, and were required to have a response (complete response \[CR\], complete response unconfirmed \[CRu\], partial response \[PR\]) to be eligible for Tositumomab and iodine I 131 tositumomab (TST/I 131 TST) therapy.
Study:
NCT01868035
Study Brief:
Results Section:
NCT01868035